| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |